Bacterial Infections Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Bacterial Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 15 of 5 trials

Recruiting
Phase 3

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Non-Hodgkin LymphomaBacterial InfectionsHypogammaglobulinemia+2 more
Grifols Therapeutics LLC386 enrolled61 locationsNCT05645107
Recruiting
Phase 2

Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV

Gram Negative PneumoniaGram-Negative Bacterial InfectionsBacteremia Caused by Gram-Negative Bacteria
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation234 enrolled2 locationsNCT06135350
Recruiting

Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens

Bacterial Infections
GramEye15,000 enrolled1 locationNCT06554145
Recruiting

Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO

Acute Lymphoblastic LeukemiaInfectionsViral Infection+4 more
Gruppo Italiano Malattie EMatologiche dell'Adulto158 enrolled1 locationNCT06025682
Recruiting
Not Applicable

Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD

Pulmonary Disease, Chronic ObstructiveBacterial Infections
University Hospital, Lille100 enrolled4 locationsNCT02655302